Prevalence of Iron Deficiency Anemia in Gynecological Cancer Patients Undergoing Treatment: A Two-Institution Retrospective Study

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Dec 23

PMID 39712704

Authors

Taro Yagi

Yasuto Kinose

Mai Koizumi

Tadashi Iwamiya

Futa Ito

Satoshi Kubota

Kenjiro Sawada

Tadashi Kimura

Masahiko Takemura

Ken-Ichirou Morishige

Affiliations

Soon will be listed here.

Abstract

Background: Anemia in patients with cancer negatively affects their quality of life and cancer outcomes. However, most patients with chemotherapy-induced anemia (CIA) are not appropriately evaluated or treated, and the prevalence of iron deficiency anemia (IDA) in CIA remains unclear.

Methods: We retrospectively reviewed the electronic records of patients with gynecological cancer in two tertiary hospitals, between March 2023 and July 2023, and evaluated their anemia status.

Results: We identified 54 patients with CIA, and IDA was found in 74% (40/54) of patients with CIA, including 4% (2/54) with absolute iron deficiency (transferrin saturation (TSAT) < 20% and ferritin < 30 ng/mL), 63% (34/54) with functional iron deficiency (TSAT < 50% and 30 ng/mL < ferritin < 500 ng/mL), and 7% (4/54) with possible functional iron deficiency (TSAT < 50% and 500 ng/mL < ferritin < 800 ng/mL).

Conclusions: We found that 74% of patients with CIA under gynecologic cancer treatments were IDA in this study.

References

Zayed S, Nguyen T, Lin C, Boldt G, Beriwal S, Creutzberg C . Red Blood Cell Transfusion Practices for Patients With Cervical Cancer Undergoing Radiotherapy. JAMA Netw Open. 2021; 4(4):e213531. PMC: 8022218. DOI: 10.1001/jamanetworkopen.2021.3531. View

Beale A, Penney M, Allison M . The prevalence of iron deficiency among patients presenting with colorectal cancer. Colorectal Dis. 2005; 7(4):398-402. DOI: 10.1111/j.1463-1318.2005.00789.x. View

Friedlander M, Lee Y, Tew W . Managing Adverse Effects Associated With Poly (ADP-ribose) Polymerase Inhibitors in Ovarian Cancer: A Synthesis of Clinical Trial and Real-World Data. Am Soc Clin Oncol Educ Book. 2023; 43:e390876. DOI: 10.1200/EDBK_390876. View

Havrilesky L, Reiner M, Morrow P, Watson H, Crawford J . A review of relative dose intensity and survival in patients with metastatic solid tumors. Crit Rev Oncol Hematol. 2014; 93(3):203-10. DOI: 10.1016/j.critrevonc.2014.10.006. View

Tanaka A, Yoshino I, Makino S, Katsumata N, Takahashi K, Kuwano H . Questionnaire-based survey on chemotherapy-induced anemia. Int J Clin Oncol. 2014; 19(3):411-20. DOI: 10.1007/s10147-014-0677-3. View

Rodgers G, Gilreath J . The Role of Intravenous Iron in the Treatment of Anemia Associated with Cancer and Chemotherapy. Acta Haematol. 2019; 142(1):13-20. DOI: 10.1159/000496967. View

Becker P, Griffiths E, Alwan L, Bachiashvili K, Brown A, Cool R . NCCN Guidelines Insights: Hematopoietic Growth Factors, Version 1.2020. J Natl Compr Canc Netw. 2020; 18(1):12-22. DOI: 10.6004/jnccn.2020.0002. View

Hufnagel D, Mehta S, Ezekwe C, Brown A, Beeghly-Fadiel A, Prescott L . Prevalence of Anemia and Compliance With NCCN Guidelines for Evaluation and Treatment of Anemia in Patients With Gynecologic Cancer. J Natl Compr Canc Netw. 2021; 19(5):513-520. DOI: 10.6004/jnccn.2020.7638. View

Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gascon P, Glaspy J . Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2018; 29(Suppl 4):iv271. DOI: 10.1093/annonc/mdy323. View

10.

Kuvibidila S, Gauthier T, Rayford W . Serum ferritin levels and transferrin saturation in men with prostate cancer. J Natl Med Assoc. 2004; 96(5):641-9. PMC: 2640669. View

11.

Dangsuwan P, Manchana T . Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy. Gynecol Oncol. 2010; 116(3):522-5. DOI: 10.1016/j.ygyno.2009.12.004. View

12.

Ludwig H, Muldur E, Endler G, Hubl W . Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia. Ann Oncol. 2013; 24(7):1886-1892. PMC: 3690908. DOI: 10.1093/annonc/mdt118. View

13.

Athibovonsuk P, Manchana T, Sirisabya N . Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy. Gynecol Oncol. 2013; 131(3):679-82. DOI: 10.1016/j.ygyno.2013.09.028. View

14.

Abdel-Razeq H, Hashem H . Recent update in the pathogenesis and treatment of chemotherapy and cancer induced anemia. Crit Rev Oncol Hematol. 2019; 145:102837. DOI: 10.1016/j.critrevonc.2019.102837. View